Related Experiment Videos

The sequence of the hemoregulatory peptide is present in Gi alpha proteins

O D Laerum1, S Frostad, H I Tøn

  • 1Gade Institute, Department of Pathology, University of Bergen, Haukeland Hospital, Norway.

FEBS Letters
|August 20, 1990
PubMed

Insights

The hemoregulatory peptide HP5b inhibits blood cell formation by mimicking a Gi alpha protein motif. Its activity depends on sequence similarity and an intact N-terminus, suggesting interference with Gi alpha signaling pathways.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Hematology

Background:

  • The hemoregulatory peptide PyroGlu-Glu-Asp-Cys-Lys (HP5b) inhibits myelopoietic colony formation in vitro.
  • HP5b contains a sequence motif also found in the effector domain of Gi alpha proteins.

Purpose of the Study:

  • To investigate the relationship between HP5b sequence variations and biological activity.
  • To determine if HP5b's inhibitory effect is linked to Gi alpha proteins and signal transduction.

Main Methods:

  • Synthesis of 8 variant peptides based on the HP5b sequence.
  • Assay of biological activity of synthetic peptides in inhibiting myelopoietic colony formation.
  • Comparison of peptide sequences with the Gi alpha protein sequence.

Main Results:

  • Synthetic peptides with sequences closely resembling the Gi alpha protein motif exhibited biological activity.
  • The inhibitory effect of HP5b and its analogs was dependent on a blocked N-terminus.
  • A correlation was observed between sequence similarity to Gi alpha and inhibitory potency.

Conclusions:

  • The hemoregulatory peptide HP5b shares a sequence motif with Gi alpha proteins, suggesting a common functional domain.
  • HP5b's inhibitory activity on myelopoiesis is mediated through interference with Gi alpha-dependent signal transduction.
  • The N-terminus of HP5b plays a crucial role in its biological activity, likely by stabilizing its interaction with target proteins.

Related Concept Videos